Retatrutide
GLP/GIP/Glucagon Triple Agonist ยท 10 mg
Retatrutide (GLP-RT) is a tri-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research interest centers on its differential engagement of all three pathways compared to dual-agonist compounds, with ongoing clinical studies investigating metabolic and body composition endpoints.